Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Patients

Adherence to high intensity statins drops off for heart attack patients

Better insurance for drug costs, more specialist visits and taking part in cardiac rehabilitation could improve adherence to recommended statin treatment, researchers believe.

patients-engage-in-cardiac-rehabilitation

Source: BSIP SA / Alamy Stock Photo

Researchers believe that cardiac rehabilitation may improve high intensity statin use and adherence after heart attack.

Patients prescribed high-intensity statins following hospitalisation for a myocardial infarction do not continue taking these drugs with high adherence at two years after discharge, according to a study published in JAMA Cardiology[1] (online, 19 April 2017). 

Researchers found that only 41.6% of patients aged between 66 and 75 years who filled a high intensity statin prescription 30 days after being admitted to hospital after a myocardial infarction, were still taking the medicine as prescribed two years later. 

African-American and Hispanic patients, as well as those who were new high statin users, were less likely to have high adherence. They found high adherence was more likely in patients who had dual medical health insurance, completed more cardiology visits post discharge and who took part in cardio rehabilitation. 

The authors suggest: “Lower medication costs, cardiologist visits, and cardiac rehabilitation may contribute to improving high intensity statin use and adherence after myocardial infarction.” 

Their results were based on an analysis of 29,932 Medicare health insurance patients aged 66 to 75 and 27, 956 aged over 75 who were hospitalised following a myocardial infarction between 2007 and 2012. 

All of the patients had filled a prescription for a high intensity statin (atorvastatin 40mg–80mg and rosuvastatin 20mg–40mg) within 30 days of being discharged from hospital. 

While 41.6% of patients had high adherence at two years, the researchers discovered that another 8.7% of patients aged between 66 and 75 years had down-titrated to a low or moderate-intensity statin after six months but still maintained high adherence. They also found that 17.3% of patients had low statin adherence at six months and 12.4% discontinued their prescribed statins altogether at six months.

Adherence was measured as a proportion of days covered “of at least 80%”. The trend was similar for patients aged over 75 years, the team found. 

Paul Wright, lead cardiac pharmacist at Barts Heart Centre, Barts Health NHS Trust, comments: “It is known that adherence to long-term medication is relatively poor and I am not surprised by the low figures at two years. The longer from the index event (a mycocardial infarction), the less likely patients are going to remain committed to long-term lifestyle changes (including taking medication).” 

He also points out there was an increase in adherence year on year over the data collection period 2007–2012.

“This may be as a result of improving access to cardiac rehabilitation and an awareness of the importance in achieving medication adherence with patients.”  

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202643

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £37.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £42.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £37.00Buy now
  • Non-medical Prescribing

    Non-medical Prescribing

    An essential new guide designed to ensure confident prescribing in specialist areas.

    £26.00Buy now
  • Non-prescription Medicines

    Non-prescription Medicines

    Reviews over-the-counter medicines, arranged by the conditions they are licensed to treat. Includes product recommendations.

    £37.00Buy now
  • Biological Therapeutics

    Biological Therapeutics

    An introduction to the treatment of disease using biological medicines derived from living plant and animal tissues.

    £32.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • patients-engage-in-cardiac-rehabilitation

Jobs you might like

See more jobs

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.